J Li, R Inoue, Y Togashi, T Okuyama, A Satoh… - Diabetes, 2022 - Am Diabetes Assoc
The effects of imeglimin, a novel antidiabetes agent, on β-cell function remain unclear. Here,
we unveiled the impact of imeglimin on β-cell survival. Treatment with imeglimin augmented …